Details of the Drug

General Information of Drug (ID: DMQYK7Y)

• Drug Name: Anti-CD19 "armored" CAR-Tcell therapy

Indication

Disease Entry	ICD 11	Status	REF
Chronic lymphocytic leukaemia	2A82.0	Phase 1	[1]

• Cross-matching ID: TTD ID: D0NW8L

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)